# A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

> **NCT02994251** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 1 (actual)

## Conditions studied

- Unresectable Intrahepatic Cholangiocarcinoma

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** Cisplatin
- **DRUG:** Conventional TACE (transarterial chemoembolization) with Doxorubicin/Mitomycin-C

## Key facts

- **NCT ID:** NCT02994251
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-21
- **Primary completion:** 2018-11-06
- **Final completion:** 2018-11-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to low enrollment making it unlikely to meet recruitment goals.
- **Last updated:** 2019-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994251, "A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02994251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*